Cdk2/Cyclin Inhibitory Peptide II
Cdk2/Cyclin Inhibitory Peptide II (Tat-LDL), a CDK2 inhibitor, kills U2OS osteosarcoma cells in a dose-dependent manner.
For research use only. We do not sell to patients.
- CAS No.: 237392-85-7
- Formula: C110H200N48O25
- Molecular Weight:2595.07
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
CDK[1].
Cdk2/Cyclin Inhibitory Peptide II (0-150 µM; 24 h) kills U2OS osteosarcoma cells in a dose-dependent manner[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:U2OS osteosarcoma cells
-
Concentration:0-150 µM
-
Incubation Time:24 h
-
Result:Exhibited good activity to kill U2OS osteosarcoma cells.
Chemical Information
-
CAS No. 237392-85-7
-
Molecular Weight 2595.07
-
Formula C110H200N48O25
-
SMILES
[YGRKKRRQRRRGPVKRRLDL]
-
Sequence Shortening
YGRKKRRQRRRGPVKRRLDL
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)